Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Pan Cancer T Secures €4.25 Million to Advance Next-Generation T Cell Therapies in Seed Extension Round

Friday, July 12, 2024

Pan Cancer T BV a biotech startup focusing on advancing T cell therapies for solid cancers has successfully closed a million Seed Extension round This funding includes

Skyhawk Therapeutics Reports Positive Results for SKY-0515 in Huntington's Disease Phase I Trial, Demonstrating Up to 72% Reduction in Huntingtin Protein mRNA

Friday, July 12, 2024

Skyhawk Therapeutics Inc has announced positive results from Parts A and B of its Phase clinical trial

AusperBio's AHB-137 Receives Breakthrough Therapy Designation for Chronic Hepatitis B Treatment

Thursday, July 11, 2024

AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd have announced that their investigational drug AHB has received Breakthrough Therapy Designation

XyloCor and SmartCella Collaborate on License Agreement for Extroducer in Novel Gene Therapy XC001 Targeting Heart Treatment

Thursday, July 11, 2024

XyloCor Therapeutics Inc a company advancing gene therapies for cardiovascular diseases has partnered with SmartWise a unit of SmartCella Holding AB to license the Extroducer Infusion Catheter

Curium Submits NDA for Lutetium Lu 177 Dotatate Injection

Wednesday, July 10, 2024

Curium a leader in nuclear medicine announced today the submission of a b New Drug Application for Lutetium Lu Dotatate Injection This application seeks FDA approval for treating somatostatin receptorpositive gastroenteropancreatic neuroendocrine tu...

Abata Therapeutics Gets FDA Approval to Start Clinical Trials of ABA-101 for Progressive Multiple Sclerosis

Tuesday, July 09, 2024

Abata Therapeutics has received clearance from the US Food and Drug Administration for its Investigational New Drug application to conduct a Phase study of ABA in patients

RS BioTherapeutics and University of Colorado School of Medicine Announce Research Collaboration

Monday, July 08, 2024

RS BioTherapeutics has entered into a collaboration with the University of Colorado School of Medicine to evaluate their novel steroidfree therapeutic platform RSBT for treating lethal lung diseases

AusperBio Reports Significant Progress in Advancing AHB-137 Clinical Development

Friday, July 05, 2024

AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd a biotechnology firm specializing in oligonucleotide therapies have made significant strides in developing AHB their lead candidate for treating chronic hepatitis B CHB infection

Pentixapharm Completes Acquisition of Glycotope's Target Discovery Division

Thursday, July 04, 2024

Pentixapharm AG a clinicalstage biotech company specializing in developing targeted radiopharmaceuticals for treating cancer has acquired Glycotope GmbHs target discovery business effective July st This acquisition includes a portfolio of preclinical...

Owkin Expands AI-Biotech Presence into Germany, Austria, and Switzerland to Enhance Research Acceleration

Wednesday, July 03, 2024

Owkin a prominent AIbiotech firm has expanded into the DACH region by forming partnerships with nine leading institutions These include Charit Universittsmedizin Berlin

Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024